KPRXKIORA PHARMACEUTICALS INC

Nasdaq kiorapharma.com


$ 3.88 $ 0.28 (7.45 %)    

Monday, 19-Aug-2024 10:33:02 EDT
QQQ $ 481.15 $ 6.24 (1.31 %)
DIA $ 409.09 $ 2.37 (0.58 %)
SPY $ 559.11 $ 5.30 (0.96 %)
TLT $ 97.90 $ 0.45 (0.46 %)
GLD $ 231.62 $ -0.38 (-0.16 %)
$ 4.04
$ 3.88
$ 3.34 x 134
-- x --
$ 3.88 - $ 3.88
$ 3.00 - $ 8.98
34,007
na
16.85M
$ 0.84
$ 5.27
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-09-2024 06-30-2024 10-Q
2 05-10-2024 03-31-2024 10-Q
3 03-25-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-23-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-12-2022 06-30-2022 10-Q
10 07-08-2022 03-31-2022 10-Q
11 04-15-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-12-2021 03-31-2021 10-Q
15 03-25-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-06-2020 03-31-2020 10-Q
19 03-04-2020 12-31-2019 10-K
20 11-07-2019 09-30-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
22 05-08-2019 03-31-2019 10-Q
23 03-01-2019 12-31-2018 10-K
24 11-13-2018 09-30-2018 10-Q
25 08-03-2018 06-30-2018 10-Q
26 05-11-2018 03-31-2018 10-Q
27 03-02-2018 12-31-2017 10-K
28 11-14-2017 09-30-2017 10-Q
29 08-04-2017 06-30-2017 10-Q
30 05-05-2017 03-31-2017 10-Q
31 02-23-2017 12-31-2016 10-K
32 11-01-2016 09-30-2016 10-Q
33 08-10-2016 06-30-2016 10-Q
34 05-13-2016 03-31-2016 10-Q
35 03-30-2016 12-31-2015 10-K
36 11-12-2015 09-30-2015 10-Q
37 08-12-2015 06-30-2015 10-Q
38 05-15-2015 03-31-2015 10-Q
39 03-31-2015 12-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-kiora-pharmaceuticals-adjusts-price-target-to-10-1-9-reverse-stock-split

HC Wainwright & Co. analyst Yi Chen maintains Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy, adjusts target to $10 from $2...

 hc-wainwright--co-reiterates-buy-on-kiora-pharmaceuticals-maintains-2-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and maintains $2 price tar...

 kiora-pharmaceuticals-to-present-additional-data-from-its-abacus-1-trial-of-kio-301-in-retinitis-pigmentosa-at-arvo-2024-annual-meeting

https://www.newsfilecorp.com/release/203326

 hc-wainwright--co-maintains-buy-on-kiora-pharmaceuticals-maintains-2-price-target

HC Wainwright & Co. analyst Yi Chen maintains Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and maintains $2 price target.

 hc-wainwright--co-maintains-buy-on-kiora-pharmaceuticals-adjusts-price-target-to-2

HC Wainwright & Co. analyst Yi Chen maintains Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy, adjusts target to $2 from ...

 why-skechers-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company reported mixed fourth-quarte...

 why-meta-shares-are-trading-higher-by-over-16-here-are-20-stocks-moving-premarket

Shares of Meta Platforms, Inc. (NASDAQ: META) rose sharply in today’s pre-market trading as the company reported upbeat fourth-...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION